Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced that its direct-to-consumer (DTC) virtual health platform will launch on November 15th, making Cue’s first-of-its-kind molecular COVID-19 test available to people across the United States through Cue’s new eCommerce site and in-app shop. Individual consumers will now be able to harness the power of Cue’s COVID-19 test, which is already trusted and used by world-class organizations like Google, Mayo Clinic, the NBA, and MLB, among others. Earlier this year, the Cue COVID-19 Test for Home and Over The Counter (OTC) Use was the first molecular test to receive FDA authorization for at-home use without a prescription. Beyond COVID-19 testing needs, Cue’s new membership offering – Cue+™– will offer members 24/7 on-demand access to board certified physicians, e-prescription services, CDC-compliant test results for travel through in-app video proctoring, and same-day delivery of Cue products in a number of major markets.
Cue simplifies the COVID-19 testing process by combining the speed of rapid antigen tests with the lab-quality accuracy of PCR tests. Cue’s portable COVID-19 test showed 97.8% concordance with central lab PCR tests, as verified in an independent study conducted by Mayo Clinic1. Authorized by the FDA to test both symptomatic and asymptomatic adults and children ages two and up using a lower nasal swab, Cue’s COVID-19 test delivers a comfortable and stress-free testing experience. Test results are delivered to the user’s smart mobile device in just 20 minutes.
“We’ve had a lot of interest from the general public eager to purchase our COVID-19 tests: from parents who need to keep their kids healthy in school to international business travelers to families who want to gather safely this holiday season. We’re excited to make Cue available to a broader audience next week to deliver fast and accurate COVID-19 testing at home or on the go,” said Clint Sever, Cue’s Co-Founder and Chief Product Officer.
Cue+ membership not only meets people’s at-home testing needs but also enables them to share Cue test results and discuss other health issues with a doctor on-demand within the new Cue Health App. The Cue platform is integrated with last-mile delivery services so members can get products at home when they need them the most. And as the anticipated COVID-19 antivirals requiring time-sensitive administration come to market, Cue expects to be able to enable consumers to go from test result to physician consultation to antiviral treatment, when appropriate, within the comfort and convenience of their own homes.
“We’re pleased to be able to offer consumers our best-in-class COVID-19 tests as part of Cue’s integrated care platform, which we believe can help empower individuals and families to live their healthiest lives,” said Ayub Khattak, Co-Founder and CEO of Cue. “With Cue+ membership and our new Cue Health App, we aim to make the healthcare journey — from testing to diagnosis to treatment — more accessible, more convenient, and more timely.”
The Cue experience starts with the Cue Reader ($249), a reusable and compact device that processes each test and connects wirelessly with a user’s mobile device to deliver results in 20 minutes via the Cue Health App (for both iOS and Android). The Cue Reader is compatible with Cue’s COVID-19 Test Cartridge ($225/3-pack) and other tests that are in development. Cue’s COVID-19 tests are self-contained, single-use cartridges that make testing simple and convenient.